First personalised cancer vaccine cuts risk of disease returning in major trial
A new cancer vaccine has shown promising results in a clinical trial by reducing the risk of the disease returning. The vaccine is tailored to each patient's specific type of cancer and genetic profile. It has been hailed as a significant breakthrough in the fight against cancer.
Why it's good news: It offers hope of more effective treatment options, bringing personalized medicine closer to reality.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
A long-term study of people with Parkinson's disease found that those who were more physically active experienced less d…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →